Pricing Log in Create free account

Immunovant, Inc. (IMVT) vs Iovance Biotherapeutics, Inc. (IOVA)

Immunovant, Inc. and Iovance Biotherapeutics, Inc. are both Biotechnology companies. Iovance Biotherapeutics, Inc. is the larger, with a market value of $6.7B against $5.7B — 1.2× the size. Immunovant, Inc. has the higher net margin (0.00% vs −89.1%) and the higher return on invested capital (0.00% vs −43.0%). Across the 13 metrics below, Iovance Biotherapeutics, Inc. leads on 7 and Immunovant, Inc. on 6.

Valuation

Metric IMVT IOVA Biotechnology median
P/E n/m n/m 8.50
P/S n/m 18.81 9.71
P/B 7.47 8.31 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 17.90 9.21
Earnings yield (10.55%) (5.38%) (33.15%)
Free cash flow yield (7.55%) (4.85%) (25.50%)

Profitability

Metric IMVT IOVA Biotechnology median
Gross margin 0.00% 48.40% 65.16%
Operating margin 0.00% (92.72%) 0.00%
Net margin 0.00% (89.09%) 0.00%
Free cash flow margin 0.00% (91.21%) 0.00%
Return on equity (80.10%) (40.36%) (56.36%)
Return on assets (71.10%) (31.76%) (48.04%)
Return on invested capital 0.00% (42.96%) 0.00%

Growth

Metric IMVT IOVA Biotechnology median
Revenue growth (TTM) — 34.55% 6.02%
EPS growth (last fiscal year) (1.47%) 14.84% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMVT IOVA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.27 4.35 4.72
Net debt to EBITDA 1.69 0.82 0.96

Dividend

Metric IMVT IOVA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IMVT IOVA Biotechnology median
Market cap 5.68b 6.67b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack